Carcinomatosis — Trials

Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 74
Recruiting: 42
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: Guangzhou Medical University
Termination share: 26%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03875144	Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)(MESOTIP)	suspended	Phase 2	66	Institut du Cancer de Montpellier - Val d'AurelleOTHER	1	Feb 9, 2026	clinicaltrials
NCT01342653	Clinical Trial at Neoadjuvant Peritoneal and Systemic Chemotherapy Plus HIPEC in Gastric Carcinomatosis(HIPEC)	suspended	Phase 2	50	Hospital General Universitario Gregorio MarañonOTHER